IMMUNOLOGY AND GENETICS OF HERPES SIMPLEX KERATITIS
单纯疱疹性角膜炎的免疫学和遗传学
基本信息
- 批准号:3261916
- 负责人:
- 金额:$ 16.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-07-01 至 1989-06-30
- 项目状态:已结题
- 来源:
- 关键词:Alphaherpesvirinae T lymphocyte alleles antiviral antibody cellular pathology corneal epithelium corneal stroma ganglions genetic strain helper T lymphocyte histochemistry /cytochemistry immunochemistry immunoglobulin genes immunopathology immunoregulation immunosuppression keratitis latent virus infection linkage mapping molecular pathology monoclonal antibody suppressor T lymphocyte
项目摘要
Herpes simplex keratitis (HSK) is a major problem of epidemic proportions,
in spite of the fact that many excellent antiviral drugs exist for
treatment of episodes of active HSK. It is clear that both viral and host
immune factors collaborate to determine the eventual course of disease
expression in any individual with HSK. Unfortunately, huge gaps exist in
our understanding of the cellular and molecular events underlying the
progression of a corneal epithelial infection with herpes to more
devastating corneal stromal disease. We have discovered, using inbred
congenic strains of mice, genetically-linked controls which govern the
development of HSK which is either predominantly epithelial or
predominantly stromal. We have mapped the phenomenon to genes linked to
the Igh locus on chromosome XII. Furthermore, in preliminary experiments
we have already shown that we can modify the course of disease in those
animals which are typically susceptible to the most severe keratitis,
through immunologic strategies, so that little to no keratitis at all
develops after herpes corneal infection.
We propose in this application to study this phenomenon in more detail,
with the expectation that understanding it at a cellular and molecular
level will enable us to design therapeutic strategies which could modify
not only the degree of corneal disease developing after herpes infection,
but also the development or continuation of latent infection in the
trigeminal ganglion. We plan to study the role of helper T cells,
cytotoxic T cells, suppressor T cells, and specific antiherpes antibody and
their respective roles in both the protection from pathology and
establishment of ganglionic latency, and in the production of pathology and
facilitation of latency establishment.
单纯疱疹性角膜炎(HSK)是一个主要的流行病问题,
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES STEPHEN FOSTER其他文献
CHARLES STEPHEN FOSTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES STEPHEN FOSTER', 18)}}的其他基金
IMMUNOLOGY AND GENETICS OF HERPES SIMPLEX KERATITIS
单纯疱疹性角膜炎的免疫学和遗传学
- 批准号:
3261919 - 财政年份:1985
- 资助金额:
$ 16.42万 - 项目类别:
IMMUNOLOGY AND GENETICS OF HERPES SIMPLEX KERATITIS
单纯疱疹性角膜炎的免疫学和遗传学
- 批准号:
3261912 - 财政年份:1985
- 资助金额:
$ 16.42万 - 项目类别:
IMMUNOLOGY AND GENETICS OF HERPES SIMPLEX KERATITIS
单纯疱疹性角膜炎的免疫学和遗传学
- 批准号:
3261917 - 财政年份:1985
- 资助金额:
$ 16.42万 - 项目类别:
IMMUNOLOGY AND GENETICS OF HERPES SIMPLEX KERATITIS
单纯疱疹性角膜炎的免疫学和遗传学
- 批准号:
3261920 - 财政年份:1985
- 资助金额:
$ 16.42万 - 项目类别:
IMMUNOLOGY AND GENETICS OF HERPES SIMPLEX KERATITIS
单纯疱疹性角膜炎的免疫学和遗传学
- 批准号:
3261915 - 财政年份:1985
- 资助金额:
$ 16.42万 - 项目类别:
IMMUNOLOGY AND GENETICS OF HERPES SIMPLEX KERATITIS
单纯疱疹性角膜炎的免疫学和遗传学
- 批准号:
2159717 - 财政年份:1985
- 资助金额:
$ 16.42万 - 项目类别:
IMMUNOLOGY AND GENETICS OF HERPES SIMPLEX KERATITIS
单纯疱疹性角膜炎的免疫学和遗传学
- 批准号:
3261913 - 财政年份:1985
- 资助金额:
$ 16.42万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 16.42万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 16.42万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 16.42万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 16.42万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 16.42万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 16.42万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 16.42万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 16.42万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 16.42万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 16.42万 - 项目类别:
Discovery Grants Program - Individual